Russell Investments Group
BHVN

Russell Investments Group’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Russell Investments Group’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-58,141
Closed -$8.79M – 3028
2022
Q3 		$8.79M Sell
58,141
-19,016
-25% -$2.82M 0.02% 797
2022
Q2 		$11.2M Sell
77,157
-31,465
-29% -$4.02M 0.02% 731
2022
Q1 		$12.9M Buy
108,622
+16,150
+17% +$2.01M 0.02% 723
2021
Q4 		$12.7M Buy
92,472
+30,789
+50% +$3.92M 0.02% 790
2021
Q3 		$8.57M Buy
61,683
+7,791
+14% +$973K 0.01% 962
2021
Q2 		$5.23M Buy
53,892
+25,103
+87% +$2.04M 0.01% 1320
2021
Q1 		$1.97M Sell
28,789
-17,097
-37% -$1.38M ﹤0.01% 1882
2020
Q4 		$3.93M Sell
45,886
-44,747
-49% -$3.79M 0.01% 1380
2020
Q3 		$5.89M Buy
90,633
+17,182
+23% +$1.13M 0.01% 1040
2020
Q2 		$5.37M Buy
73,451
+5,030
+7% +$268K 0.01% 1055
2020
Q1 		$2.33M Buy
68,421
+30,523
+81% +$1.4M 0.01% 1382
2019
Q4 		$2.06M Buy
37,898
+18,707
+97% +$926K ﹤0.01% 1721
2019
Q3 		$801K Buy
+19,191
New +$811K ﹤0.01% 2112
2019
Q1 		– Sell
-12,755
Closed -$472K – 3137
2018
Q4 		$472K Buy
12,755
+258
+2% +$9.3K ﹤0.01% 2340
2018
Q3 		$469K Sell
12,497
-21,306
-63% -$784K ﹤0.01% 2415
2018
Q2 		$1.34M Hold
33,803
– – ﹤0.01% 1961
2018
Q1 		$871K Buy
+33,803
New +$1.01M ﹤0.01% 2260
2017
Q3 		– Sell
-15,535
Closed -$388K – 3120
2017
Q2 		$388K Buy
+15,535
New +$358K ﹤0.01% 2508

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

Russell Investments Group's BHVN Position: Q4 2022 in Review

Russell Investments Group sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 58,141 shares — an estimated $8.79M sold.

Russell Investments Group first reported a position in BHVN in Q2 2017 and held it in 18 quarters. The position peaked at $12.9M in Q1 2022. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • Russell Investments Group reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • Russell Investments Group sold 58,141 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $8.79M.
  • Russell Investments Group first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2017 and held it in 18 quarters.
  • Russell Investments Group's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $12.9M in Q1 2022.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on Russell Investments Group's 13F filing for Q4 2022, filed 8 Feb 2023.